Cargando…
Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus
BACKGROUND: The immunomodulatory drug leflunomide (LEF) is frequently used for treating human cytomegalovirus (HCMV), but its antiviral mechanism is still unclear. In this study,we therefore investigated the effects of the active LEF metabolite A771726 on the HCMV lifecycle in human embryonic lung f...
Autores principales: | Qi, Ren, Hua-Song, Zeng, Xiao-Feng, Zeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598351/ https://www.ncbi.nlm.nih.gov/pubmed/23369524 http://dx.doi.org/10.1186/2047-783X-18-3 |
Ejemplares similares
-
Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation
por: Andrassy, Joachim, et al.
Publicado: (2009) -
Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts
Publicado: (1989) -
Calpain‐mediated cleavage of p53 in human cytomegalovirus‐infected lung fibroblasts
por: Chen, Zhenping, et al.
Publicado: (2018) -
Discrepancy between the effects of morronside on apoptosis in human embryonic lung fibroblast cells and lung cancer A549 cells
por: CHEN, JIAN-PING, et al.
Publicado: (2014) -
Leflunomide leads to inhibition of transendothelial migration
por: Grisar, J, et al.
Publicado: (2001)